MASHINIi

MDxHealth SA.

MDXH.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

MDxHealth SA is a molecular diagnostics company based in Belgium and the United States. It focuses on the development and commercialization of epigenetic tests for cancer diagnosis and prognosis. Their primary product is SelectMDx, a urine-based molecular test to identify men at low risk of aggressi...Show More

Ethical Profile

Mixed.

MDxHealth SA demonstrates a strong commitment to 'Better Health for All' through its diagnostic tests. Its SelectMDx test reportedly saves an estimated 14,035 life years annually and has led to over $500 million in cost savings for 311,879 patients by reducing unnecessary biopsies. The test boasts a 98% negative predictive value. However, there is currently insufficient evidence to assess MDxHealth's performance regarding fair pay, ethical sourcing, environmental impact, or data security.

Value Scores

Better Health for All30
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect20
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

30

MDxHealth's core products, primarily diagnostic tests for prostate cancer and UTIs, deliver revolutionary health benefits. The SelectMDx test alone is estimated to gain 14,035 life years in full health annually and save over $500 million for a cohort of 311,879 patients by reducing unnecessary biopsies.

1
It boasts a 98% negative predictive value for significant cancer and 95% accuracy in ruling out high-grade prostate cancer, potentially reducing unnecessary biopsies by 46%.
2
The company's products have no established negative health outcomes, with all revenue derived from health-positive diagnostic tests. The SelectMDx test helps reduce complications associated with prostate biopsies, which have an 18% complication rate and 3% hospitalization rate for infection.
3
While specific pricing for SelectMDx is not provided,
4
the test is shown to generate significant cost savings for healthcare systems in multiple countries.
5
The company's focus on identifying men at low risk of aggressive prostate cancer and providing early, accurate diagnosis for UTIs aligns with preventative health measures. The company conducts prospective, multicenter validation studies for its products.
6

Fair Money & Economic Opportunity

0

MDxHealth SA is a molecular diagnostics company focused on developing and commercializing epigenetic tests for cancer diagnosis and prognosis.

1
The company's core business does not involve lending, insuring, moving, or storing money for consumers. It does not offer consumer credit products, manage customer finance data, or operate financial service access points. Therefore, the company's activities do not fall within the scope of the 'Fair Money & Economic Opportunity' value, as it does not engage in practices related to financial pricing, fees, lending, or wealth-building outcomes for consumers.

Fair Pay & Worker Respect

20

MDxHealth offers company-paid medical, dental, vision, and life insurance coverage as part of its comprehensive compensation and benefits package.

1
The company also provides a 401(k) with company match and employee discounts.
2

Fair Trade & Ethical Sourcing

0

No evidence available to assess MDxHealth SA on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess MDxHealth SA on Honest & Fair Business.

Kind to Animals

0

No evidence available to assess MDxHealth SA on Kind to Animals.

No War, No Weapons

0

No evidence available to assess MDxHealth SA on No War, No Weapons.

Planet-Friendly Business

0

No specific, concrete data points related to planet-friendly business practices, environmental performance metrics, or climate initiatives were found across the provided articles. The articles primarily focus on financial performance, product information, and general ESG risk scores without detailing specific environmental KPIs or actions.

Respect for Cultures & Communities

0

The provided articles, which include financial results, shareholder meeting details, a research collaboration, and company 'About' information, do not contain any specific data points or mentions related to MDxHealth's engagement with local or indigenous communities, cultural impact assessments, cultural preservation efforts, local employment, grievance mechanisms for communities, or any other metrics relevant to the 'Respect for Cultures & Communities' value.

Safe & Smart Tech

0

No evidence available to assess MDxHealth SA on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No information was found in the provided articles regarding MDxHealth SA's waste diversion rate, product recyclability, packaging sustainability, recycled content percentage, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.

1

Own MDxHealth SA?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.